Bristol Myers Squibb Notches Key Regulatory Win for Oral Formulation of Epigenetic Modifier
By Pavel Ryzhov, Ph.D. Acute myeloid leukemia (AML), a type of blood cancer, is an aggressive disease affecting 3-5 people per 100,000 cases in the US. The buildup of immature …
Read More